Radiomics-Based Phenotyping for Treatment Optimization of HER2+ Breast Cancer A second Ignition Award is going to ... Launching a Multiplex BRCA1/RAD51C ddPCR Methylation Assay as a Clinical HRD Test ...

Previous work from other laboratories showed that PARP inhibitors are particularly toxic to cells with defects in the homologous recombination (HR) repair pathway, including breast and ... resistance ...

A new genetic study from researchers at Michigan State University could help scientists gain a deeper understanding of where ...

The 2024 Innovator Award will cover four years of Ramanujam and her team’s work to reduce the burdens of cancer treatments on ...

A Michigan State University researcher's new model for studying breast cancer could help scientists better understand why and where cancer metastasizes.

Mabel Mardones, MD, Rocky Mountain Cancer Centers, discusses the future of HR+/HER2– breast cancer treatment, focusing on the importance of biomarkers and the potential of SIRDs to improve patient ...

Breast canceris a significant global public health challenge, with 2.3 million new cases and 700,000 deaths every year. Approximately 80% of patients with primary breast cancer can be cured, if ...

A new study adds to the evidence on hormonal contraceptives and breast cancer. But experts stressed the overall risk remains low. By Nina Agrawal A study published Wednesday found that women using ...

Male breast cancer, though rare, affects about 1% of all breast cancer patients globally. Men often overlook symptoms, resulting in late-stage diagnoses. Risk factors include genetic mutations ...

A new study has found a link between hormonal intrauterine devices (IUDs) and breast cancer. The research is important, but media reports of a large increase in risk may be causing unnecessary worry.

CHICAGO (CBS) --As we focus on Breast Cancer Awareness Month, we have a powerful story of sisterhood and survival. At the Paint the Lake Pink Walk in north suburban Lake Zurich, honoring loved ...